Recombinant Anti-CD19 & Anti-CD64 Bispecific Antibody (BsFab) is composed of the Fab of the anti-CD19 monoclonal antibody and Fab of an antibody specific for CD64. A stable thioether linkage is formed between the two Fab. The bispecific antibody is somewhat smaller than a whole IgG, and therefore it clears from the blood naturally at a faster rate. It was designed for the treatment of non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for BSAB-L024. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.